Scarica l'app Stockscreener
35.59
2.33%
0.81
Dopo l'orario di chiusura:
35.59
Precedente Chiudi:
$34.78
Aprire:
$34.56
Volume 24 ore:
1.07M
Relative Volume:
0.93
Capitalizzazione di mercato:
$2.65B
Reddito:
-
Utile/perdita netta:
$-301.06M
Rapporto P/E:
-7.308
EPS:
-4.87
Flusso di cassa netto:
$-248.01M
1 W Prestazione:
-7.08%
1M Prestazione:
-4.94%
6M Prestazione:
-1.69%
1 anno Prestazione:
+11.32%
Intervallo 1D:
$34.56
$35.94
Intervallo di 1 settimana:
$34.35
$38.83
Portata 52W:
$28.21
$53.92
Springworks Therapeutics Inc Stock (SWTX) Company Profile
Nome
Springworks Therapeutics Inc
Settore
Industria
Telefono
203-883-9490
Indirizzo
100 WASHINGTON BOULEVARD, STAMFORD, CT
Confronta SWTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SWTX
Springworks Therapeutics Inc
|
35.59 | 2.65B | 0 | -301.06M | -248.01M | -4.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-20 | Iniziato | Evercore ISI | Outperform |
| 2024-02-05 | Iniziato | Guggenheim | Buy |
| 2022-12-01 | Iniziato | BofA Securities | Buy |
| 2021-01-19 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-29 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-05 | Iniziato | Barclays | Overweight |
| 2020-03-19 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-01-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-12-04 | Iniziato | H.C. Wainwright | Buy |
| 2019-10-08 | Iniziato | Cowen | Outperform |
| 2019-10-08 | Iniziato | Goldman | Buy |
| 2019-10-08 | Iniziato | JP Morgan | Overweight |
| 2019-10-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Springworks Therapeutics Inc Borsa (SWTX) Ultime notizie
Barclays PLC Purchases 58,645 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.
(SWTX) On The My Stocks Page - Stock Traders Daily
Comparing Titan Pharmaceuticals (NASDAQ:TTNP) & SpringWorks Therapeutics (NASDAQ:SWTX) - Defense World
Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm - GuruFocus.com
Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's Top 2 Picks - Seeking Alpha
SpringWorks Therapeutics' SWOT analysis: stock potential amid clinical progress By Investing.com - Investing.com South Africa
SpringWorks Therapeutics' SWOT analysis: stock potential amid clinical progress - Investing.com India
Lord Abbett & CO. LLC Has $34.27 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.20 Million Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (SWTX) Up 14.5% Since Last Earnings Report: Can It Continue? - MSN
Main Management ETF Advisors LLC Buys Shares of 23,280 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Charles Schwab Investment Management Inc. Raises Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
(SWTX) Trading Report - Stock Traders Daily
Soros Fund Management LLC Acquires 174,321 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Insider Sell Alert: Badreddin Edris Sells 20,000 Shares of Sprin - GuruFocus.com
Springworks Therapeutics COO sells $839,335 in stock By Investing.com - Investing.com UK
Erste Asset Management GmbH Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Springworks Therapeutics CEO Islam Saqib sells $2 million in stock - Investing.com
Springworks Therapeutics CEO Islam Saqib sells $2 million in stock By Investing.com - Investing.com Nigeria
Saqib Islam Sells 49,000 Shares of SpringWorks Therapeutics Inc (SWTX) - GuruFocus.com
High Growth Tech Stocks to Watch in December 2024 - Simply Wall St
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Position Boosted by The Manufacturers Life Insurance Company - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by HighVista Strategies LLC - MarketBeat
Walleye Capital LLC Boosts Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Fmr LLC Boosts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Intech Investment Management LLC Invests $676,000 in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Dynamic Technology Lab Private Ltd Buys Shares of 13,717 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Ally Bridge Group NY LLC Invests $7.30 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference - The Manila Times
SpringWorks Therapeutics to Present at Evercore ISI HealthCONx Conference | SWTX Stock News - StockTitan
Massachusetts Financial Services Co. MA Boosts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
(SWTX) Investment Analysis - Stock Traders Daily
SpringWorks Therapeutics' SWOT analysis: stock shows promise amid challenges - Investing.com
Alpha DNA Investment Management LLC Makes New $411,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
GSA Capital Partners LLP Makes New $209,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Eagle Asset Management Inc. Sells 54,366 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Trading 8.1% HigherShould You Buy? - MarketBeat
SpringWorks Therapeutics Inc. (SWTX): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts - Insider Monkey
Evercore ISI Begins Coverage on SpringWorks Therapeutics (NASDAQ:SWTX) - Defense World
SpringWorks started at outperform by Evercore ahead of FDA decision - MSN
Does SpringWorks Therapeutics (SWTX) Have the Potential to Rally 92.68% as Wall Street Analysts Expect? - MSN
SpringWorks' Q3 Loss Narrower Than Expected, Revenues Miss Mark - MSN
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Position Boosted by Victory Capital Management Inc. - MarketBeat
SpringWorks Therapeutics: Q3 Earnings Snapshot - AOL
Equities Analysts Set Expectations for SWTX FY2024 Earnings - Defense World
Wedbush Has Negative Forecast for SWTX FY2024 Earnings - Defense World
When (SWTX) Moves Investors should Listen - Stock Traders Daily
Analyst Estimates: Here's What Brokers Think Of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Report - Yahoo Finance
Here's What Analysts Are Forecasting For SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Results - Simply Wall St
Springworks Therapeutics Inc Azioni (SWTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Springworks Therapeutics Inc Azioni (SWTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Islam Saqib | Chief Executive Officer |
Dec 02 '24 |
Sale |
41.37 |
49,000 |
2,027,357 |
1,014,368 |
| Islam Saqib | Chief Executive Officer |
Sep 03 '24 |
Sale |
40.57 |
49,000 |
1,988,033 |
1,063,368 |
| Edris Badreddin | Chief Operating Officer |
Sep 03 '24 |
Sale |
40.65 |
20,000 |
812,954 |
229,600 |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):